Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Natera, Inc. Director's Dealing 2021

Jan 15, 2021

30253_dirs_2021-01-15_b8f9b44c-cdda-4dc3-b4ca-c800bb5fec64.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Natera, Inc. (NTRA)
CIK: 0001604821
Period of Report: 2021-01-13

Reporting Person: Chapman Steven Leonard (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-01-13 Common Stock M 1118 $10.41 Acquired 38282 Direct
2021-01-13 Common Stock M 1042 $10.73 Acquired 39324 Direct
2021-01-13 Common Stock M 1526 $9.29 Acquired 40850 Direct
2021-01-13 Common Stock M 1042 $13.01 Acquired 41892 Direct
2021-01-13 Common Stock M 1042 $20.27 Acquired 42394 Direct
2021-01-13 Common Stock M 2385 $25.46 Acquired 45319 Direct
2021-01-13 Common Stock S 8155 $115 Disposed 37164 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-01-13 Stock Option (right to buy) $10.41 M 1118 Disposed 2027-06-08 Common Stock (1118) Direct
2021-01-13 Stock Option (right to buy) $10.73 M 1042 Disposed 2027-07-13 Common Stock (1042) Direct
2021-01-13 Stock Option (right to buy) $9.29 M 1526 Disposed 2028-03-08 Common Stock (1526) Direct
2021-01-13 Stock Option (right to buy) $13.01 M 1042 Disposed 2029-01-10 Common Stock (1042) Direct
2021-01-13 Stock Option (right to buy) $20.27 M 1042 Disposed 2029-04-11 Common Stock (1042) Direct
2021-01-13 Stock Option (right to buy) $25.46 M 2385 Disposed 2030-03-26 Common Stock (2385) Direct

Footnotes

F1: The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.

F2: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.

F3: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 12, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.

F4: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.

F5: The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.

F6: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.

F7: The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of October 1, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 37,500 shares.